Literature DB >> 8627647

Prognostic value of Bcl-2 and p53 expression in urinary tract transitional cell cancer.

V Bilim, Y Tomita, T Kawasaki, A Katagiri, T Imai, M Takeda, K Takahashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8627647     DOI： 10.1093/jnci/88.10.686-a

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  CC genotype of anti-apoptotic gene BCL-2 (-938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer.

Authors:  J Javid; R Mir; M Mirza; A Imtiyaz; Y Prasant; Z Mariyam; P K Julka; A Mohan; M Lone; P C Ray; A Saxena
Journal:  Clin Transl Oncol       Date:  2014-09-26       Impact factor: 3.405

2.  Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer.

Authors:  Gregory Kouraklis; John Kakisis; Stamatios Theoharis; Antonia Tzonou; Andromachi Glinavou; John Raftopoulos; Gabriel Karatzas
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

3.  Apoptosis resistance in tumor cells.

Authors:  T Mashima; H Seimiya; Z Chen; S Kataoka; T Tsuruo
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility.

Authors:  Ning Zhang; Xiaoyan Li; Kai Tao; Liyu Jiang; Tingting Ma; Shi Yan; Cunzhong Yuan; Meena S Moran; Faming Liang; Bruce G Haffty; Qifeng Yang
Journal:  BMC Med Genet       Date:  2011-04-01       Impact factor: 2.103

5.  Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.

Authors:  T Itoi; K Yamana; V Bilim; K Takahashi; F Tomita
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.